Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Press Enter ↡ to search evidence


     Quick Answer



    Psychedelics (psilocybin, LSD, DMT) act primarily as agonists at serotonin 5-HT2A receptors, triggering Gq/PLCΞ² signaling and downstream cascades including JAK2-STAT3 and Ras-ERK1/2 phosphorylation, as demonstrated for the 5-HT2A agonist DOI in cellular models . However, no supplied source directly establishes the full psychedelic neurobiological mechanism.


     Long Answer



    Core pharmacology: Classic psychedelics are agonists at serotonin receptors, most critically the 5-HT2A subtype. A signaling-dissection study using the selective 5-HT2A agonist DOI showed that receptor activation phosphorylates JAK2, driving both STAT3 Tyr705 phosphorylation and ERK1/2 activation through a PLCβ–PKCβ–Ras axis, with MEK1/2 (U0126, 25 Β΅M) and JAK2 (AG490, 30 Β΅M) inhibition fully blocking downstream effects while PI3K-AKT was activated but not required . This illustrates that 5-HT2A is a pleiotropic G-protein-coupled receptor engaging multiple transduction cascades beyond canonical Gq/PLC.

    Broader serotonergic context: Serotonin signaling varies widely by receptor subtype: 5-HT2C receptors tonically inhibit nigrostriatal dopaminergic activity, since 5-HT2C-null mice show elevated substantia nigra dopaminergic firing and striatal dopamine , and 5-HT2A vs 5-HT2C exert opposing control over psychostimulant-induced dopamine output in VTA and nucleus accumbens . Serotonin also stimulates microglial exosome secretion (~4.8-fold IDE release in BV-2 cells at 25 Β΅M 5-HT) .

    Epistemic limits: The supplied evidence covers serotonergic receptor signaling broadly but no source directly characterizes psychedelic drugs' subjective or therapeutic neural mechanisms (e.g., cortical glutamate release, neuroplasticity, entropic brain effects). Those central claims are therefore unresolved here; the clinical trials listed (psilocybin in AUD/OCD, LSD dose-ranging, SERT inhibition on LSD response ) address safety and mechanism indirectly.



    Feedback:    

    Updated: November 12, 2026

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Psychedelics act purely monoamine-transporter-mediated (like SSRIs): refuted by receptor-class specificity; 5-HT2A agonism with distinct downstream cascades (JAK2/PLCΞ²/Ras) best explains their unique profile.


    All psychedelic effects reduce to elevated extracellular serotonin: null-mutation data show 5-HT2C tonically gates dopamine independently, so receptor-subtype configuration, not bulk serotonin level, determines output.

     Science Art


    What is the mechanism behind psychedelics? Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($64 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT